Enovis (ENOV) FCF Margin (2010 - 2026)
Enovis (ENOV) reported FCF Margin of 4.9% for Q2 2026, up 313.0% year-over-year from 1.19% in Q2 2025, and down 187.32% on a QoQ basis from 5.61% in Q4 2025.
Enovis (ENOV) has 17 years of FCF Margin data on file, last reported at 4.9% in Q2 2026.
- Quarterly FCF Margin rose 313.0% year-over-year to 4.9% in Q2 2026, while the trailing twelve-month figure through Apr 2026 was 1.58% (up 339.0% YoY) and the FY2025 annual result came in at 0.89%, up 407.0% from the prior year.
- FCF Margin fell to 4.9% in Q2 2026 per ENOV's latest filing, from 5.61% in the prior quarter.
- Across five years, FCF Margin topped out at 8.89% in Q4 2023 and bottomed at 17.8% in Q4 2022.
- The 5-year median for FCF Margin is 2.03% (2023), against an average of 3.14%.
- The widest annual swing landed in 2022, when FCF Margin plunged 3423 bps; it then soared 2669 bps in 2023.
- Tracing ENOV's FCF Margin over 5 years: stood at 17.8% in 2022, then soared by 150 bps to 8.89% in 2023, then dropped by 30 bps to 6.26% in 2024, then decreased by 10 bps to 5.61% in 2025, then tumbled by 187 bps to 4.9% in 2026.
- Per Business Quant, the three latest ENOV FCF Margin figures stand at 4.9% (Q2 2026), 5.61% (Q4 2025), and 5.3% (Q4 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 8.20% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 6.89% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 25.51% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 3.29% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | -1.28% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 6.68% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 37.67% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 3.98% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 15.44% |
| 10 | Enovis | 1.25 Bn | 1.22 Bn | 365.49 Mn | -4.90% |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 3, 2026 | -4.90% |
| Dec 31, 2025 | 5.61% |
| Oct 3, 2025 | 5.30% |
| Jul 4, 2025 | 0.60% |
| Apr 4, 2025 | -8.03% |
| Dec 31, 2024 | 6.26% |
| Sep 27, 2024 | 0.47% |
| Jun 28, 2024 | -6.02% |
| Mar 29, 2024 | -14.16% |
| Dec 31, 2023 | 8.89% |
| Sep 29, 2023 | 0.95% |
| Jun 30, 2023 | -2.03% |
| Mar 31, 2023 | -5.66% |
| Dec 31, 2022 | -17.80% |
| Sep 30, 2022 | -0.38% |
| Jul 1, 2022 | -12.30% |
| Apr 1, 2022 | -10.26% |
| Dec 31, 2021 | 16.43% |
| Oct 1, 2021 | 18.94% |
| Jul 2, 2021 | 16.36% |
| Apr 2, 2021 | 19.24% |
| Dec 31, 2020 | 11.54% |
| Oct 2, 2020 | 6.05% |
| Jul 3, 2020 | 2.85% |
| Apr 3, 2020 | 3.08% |
| Dec 31, 2019 | 4.52% |
| Sep 27, 2019 | 2.23% |
| Jun 28, 2019 | 4.75% |
| Mar 29, 2019 | -14.13% |
| Dec 31, 2018 | 16.73% |
| Sep 28, 2018 | 9.87% |
| Jun 29, 2018 | 4.03% |
| Mar 30, 2018 | -2.58% |
| Dec 31, 2017 | 8.25% |
| Sep 29, 2017 | 0.73% |
| Jun 30, 2017 | 5.08% |
| Mar 31, 2017 | 3.91% |
| Dec 31, 2016 | 15.21% |
| Sep 30, 2016 | 3.82% |
| Jul 1, 2016 | 3.66% |
| Apr 1, 2016 | 0.02% |
| Dec 31, 2015 | 10.79% |
| Sep 25, 2015 | 7.31% |
| Jun 26, 2015 | 6.02% |
| Mar 27, 2015 | -1.45% |
| Dec 31, 2014 | 13.17% |
| Sep 26, 2014 | 12.68% |
| Jun 27, 2014 | 6.21% |
| Mar 28, 2014 | -7.55% |
| Dec 31, 2013 | 13.21% |
| Sep 27, 2013 | 8.47% |
| Jun 28, 2013 | 7.58% |
| Mar 29, 2013 | -3.31% |
| Dec 31, 2012 | 13.64% |
| Sep 28, 2012 | 2.39% |
| Jun 29, 2012 | 5.37% |
| Mar 30, 2012 | -14.46% |
| Dec 31, 2011 | 7.07% |
| Sep 30, 2011 | 5.24% |
| Jul 1, 2011 | 10.91% |
| Apr 1, 2011 | 1.06% |
| Dec 31, 2010 | 14.06% |
| Oct 1, 2010 | 3.03% |